What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing by Thermo Fisher Scientific (TMO) is to officially report and furnish its financial results for the fiscal quarter ended December 31, 2020, through an attached press release (Exhibit 99.1).

Is the financial information in the press release legally 'filed' with the SEC?

No, the information contained in the press release (Exhibit 99.1) is considered 'furnished,' not 'filed,' under Section 18 of the Exchange Act. This means it is provided for informational purposes and does not subject the company to the same liabilities as 'filed' information.

What are the key risks mentioned in the filing that could impact TMO's future performance?

The filing highlights risks such as the ongoing impact and duration of the COVID-19 pandemic, the company's ability to develop new products and adapt to technological changes, general economic conditions, customer spending policies, government funding, international operational challenges, and the potential non-realization of expected benefits from acquisitions.

Where can I find more detailed information about the risks facing Thermo Fisher Scientific?

Investors are advised to consult Thermo Fisher Scientific's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, specifically the 'Risk Factors' section, for a comprehensive understanding of potential risks and uncertainties.

TMO 8-K: Earnings & Results

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on February 1, 2021, to report its financial results for the fiscal quarter ended December 31, 2020. The primary purpose of this filing is to furnish the press release announcing these results, which is included as Exhibit 99.1. While the 8-K itself is a formal SEC filing, the information presented within the attached press release is furnished and not deemed "filed" under the Exchange Act, meaning it doesn't carry the same legal liabilities. Investors should refer to the press release for the detailed financial performance and operational updates for the quarter. The filing also includes a standard cautionary statement regarding forward-looking statements, reminding investors that actual results could differ materially from projections due to various risks and uncertainties. These risks include, but are not limited to, the ongoing impact of the COVID-19 pandemic, product development, economic conditions, and geopolitical factors. Investors are encouraged to review TMO's other SEC filings, such as its 10-K and 10-Q reports, for a comprehensive understanding of these risks.

Key Highlights

1Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended December 31, 2020, via an 8-K filing on February 1, 2021.
2The 8-K filing primarily serves to furnish the press release containing the company's quarterly financial results (Exhibit 99.1).
3Information within the press release is furnished, not 'filed,' meaning it's provided for informational purposes without the same legal implications of a 'filed' document.
4The filing includes a cautionary note about forward-looking statements, highlighting potential risks and uncertainties that could affect actual results.
5Key risks mentioned include the duration and severity of the COVID-19 pandemic, technological changes, economic conditions, and international operational factors.
6Investors are directed to TMO's 10-K and 10-Q filings for a detailed discussion of risk factors.
7The filing incorporates by reference the press release dated February 1, 2021, as Exhibit 99.1.

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Feb 1, 2021)

Summary

Key Highlights

Frequently Asked Questions